<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Journal of Clinical Investigation"><meta name="citation_title" content="Chemokines and atherosclerosis: what Adam Smith has to say about vascular disease"><meta name="citation_authors" content="Barrett J. Rollins"><meta name="citation_date" content="2001 November 1"><meta name="citation_issue" content="9"><meta name="citation_volume" content="108"><meta name="citation_firstpage" content="1269"><meta name="citation_doi" content="10.1172/JCI14273"><meta name="citation_pdf_url" content="http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=209448&amp;blobtype=pdf"><meta name="citation_fulltext_html_url" content="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=209448"><meta name="citation_pmid" content="11696568"><meta name="DC.Title" content="Chemokines and atherosclerosis: what Adam Smith has to say about vascular disease"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="American Society for Clinical Investigation"><meta name="DC.Contributor" content="Barrett J. Rollins"><meta name="DC.Date" content="2001 November 1"><meta name="DC.Identifier" content="10.1172/JCI14273"><meta name="DC.Language" content="en"><link rel="stylesheet" href="corehtml/pmc/css/pmcstatic.css" type="text/css"><link rel="stylesheet" href="corehtml/pmc/css/pmcbase1.css" type="text/css"><link rel="stylesheet" href="corehtml/pmc/css/pmcbars-black.css" type="text/css"><link rel="stylesheet" href="corehtml/pmc/css/pmcbody1.css" type="text/css"><link rel="stylesheet" href="corehtml/pmc/css/pmcrefs2.css" type="text/css"><script type="text/javascript" src="corehtml/pmc/js/common.js"></script><script type="text/javascript">window.name="mainwindow";</script><link href="http://www.ncbi.nlm.nih.gov/corehtml/jsutils/css/tileshop_pmc.1/tileshop_pmc.1.css" type="text/css" rel="stylesheet"><script type="text/javascript" src="http://www.ncbi.nlm.nih.gov/corehtml/jsutils/utils.1.js"></script><script>utils.jsLoader.sBase = "http://www.ncbi.nlm.nih.gov/corehtml/jsutils/";</script><script type="text/javascript" src="http://www.ncbi.nlm.nih.gov/corehtml/jsutils/tileshop_pmc.1/tileshop_pmc.1.js"></script><script type="text/javascript" src="http://www.ncbi.nlm.nih.gov/corecgi/tileshop/tileshop_data_db.1.js"></script><title>Chemokines and atherosclerosis: what Adam Smith has to say about vascular disease</title></head><body class="pmc-body"><a id="top" name="top"></a><table cellpadding="0" cellspacing="0" width="100%" border="0"><tr valign="top"><td colspan="3"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse: collapse;"><tr><td width="145" valign="top"><img src="corehtml/pmc/pmcgifs/pmc3_logo_v5.gif" border="0" usemap="#pmclogo" alt="pmc logo image"><map name="pmclogo"><area shape="rect" alt="Journal List" coords="65,52,137,67" href="fprender.fcgi"><area shape="rect" alt="Search" coords="7,52,52,67" href="redirect3.cgi?&amp;&amp;auth=0J5j0kAjZyXmTGdlVP1eUVNpIjrA_OpySywApqAZU&amp;reftype=other&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CLogo&amp;TO=Entrez%7CSearch%7CAll%20PMC&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pmc"><area shape="rect" alt="pmc logo image" coords="0,0,145,75" href="./"></map></td><td height="75" valign="top" style="padding-left: 4px;"><div><img align="top" border="0" src="corehtml/pmc/pmcgifs/logo-jcinvest_o.gif" alt="Logo of jcinvest" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="149,50,237,75" href="tocrender.fcgi?journal=120" alt="Current issue" title="Current issue" target="mainwindow" onclick="focuswin('mainwindow')"><area shape="rect" coords="238,50,298,75" href="tocrender.fcgi?journal=120&amp;action=archive" alt="Archive" title="Archive" target="mainwindow" onclick="focuswin('mainwindow')"><area shape="rect" coords="299,50,384,75" href="redirect3.cgi?&amp;&amp;auth=0T1JFuWD02aZHuOe4wDBXlMrj98NIRR6BrHBUok5H&amp;reftype=publisher&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN%2FA&amp;rendering-type=normal&amp;&amp;http://www.jci.org/subscriptions/" alt="Subscribe to the JCI" title="Subscribe to the JCI" target="pmc_ext" onclick="focuswin('pmc_ext')"><area shape="rect" coords="385,50,500,75" href="redirect3.cgi?&amp;&amp;auth=06WrD7IDIqaiCc9afVYDyBdAdSmfBrvsMq9mp1kqv&amp;reftype=publisher&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN%2FA&amp;rendering-type=normal&amp;&amp;http://www.jci.org/misc/info.shtml" alt="About the JCI" title="About the JCI" target="pmc_ext" onclick="focuswin('pmc_ext')"><area shape="DEFAULT" coords="0,0,500,75" href="redirect3.cgi?&amp;&amp;auth=0hUIk4ofgLh-S0-A_yihzv1WlA4avBNl43rSuKkat&amp;reftype=publisher&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN%2FA&amp;rendering-type=normal&amp;&amp;http://www.jci.org" alt="The Journal of Clinical Investigation" title="The Journal of Clinical Investigation" target="pmc_ext" onclick="focuswin('pmc_ext')"></map></div></td></tr></table></td></tr></table><table cellpadding="0" cellspacing="3" width="100%" border="0"><tr><td></td><td colspan="2"><div class="navlink-box navlink-box-black"><a href="fprender.fcgi" class="navlink">Journal List</a><span> &gt; </span><a class="navlink" href="tocrender.fcgi?journal=120&amp;action=archive">J Clin Invest</a><span> &gt; </span><a class="navlink" href="tocrender.fcgi?iid=6633">v.108(9); Nov 1, 2001</a></div></td></tr><tr><td width="145" valign="top" class="sidebar-cell"><div class="sidebar-article-navigation-box"><div class="sidefm-pmccurrent-item"><a class="sidefm-pmclink" href="javascript:return(false);"><span class="sidebar-menu-square-image-holder"><img border="0" src="corehtml/pmc/pmcgifs/square.gif" alt="&gt;"></span>Full Text</a></div><div class="sidefm-pmclink-item"><a href="picrender.fcgi?artid=209448&amp;blobtype=pdf" class="sidefm-pmclink">PDF (386K)</a></div><div class="sidefm-pmclink-item"><a href="tocrender.fcgi?iid=6633" class="sidefm-pmclink">Contents</a></div><div class="sidefm-pmclink-item"><a href="tocrender.fcgi?journal=120&amp;action=archive" class="sidefm-pmclink">Archive</a></div></div><div class="sidebar-pubmed-box"><div class="sidebar-pubmed-links-to-box"><form name="pubmedLinks" onsubmit="return pubMedDbLinkSubmit(this)"><div class="sidefm-pmsubhead"><label for="pubmedOption">Related material:</label></div><select name="pubmedOption" id="pubmedOption" class="sidefm-pmart" onchange="return pubMedDbLinkSubmit(this)"><option value="redirect3.cgi?&amp;&amp;auth=00mz-DiLa6F5gY6QVCiFwalFkhkSpg1B_blhKn5l3&amp;reftype=abs&amp;refto=entrez&amp;reffrom=sidebar&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article|Navigation&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/11696568">PubMed record</option><option selected value="redirect3.cgi?&amp;&amp;auth=0VsIaTp7OtgvfmNnf7f-_co6sAFuqqNMpTyYS15w5&amp;reftype=relart&amp;refto=entrez&amp;reffrom=sidebar&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article|Navigation&amp;TO=Entrez|PubMed|Related%20Records&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Link&amp;dbFrom=PubMed&amp;from_uid=11696568">PubMed related arts</option><option value="redirect3.cgi?&amp;&amp;auth=0V_GQX-gV4WdpbqfyVKIl1Ez6JzwB48X9EUn15Ai8&amp;reftype=linkout&amp;refto=entrez&amp;reffrom=sidebar&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article|Navigation&amp;TO=Entrez|PubMed|Linkout&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;Cmd=ShowLinkOut&amp;TermToSearch=11696568">PubMed LinkOut</option><option value="redirect3.cgi?&amp;&amp;auth=0vsyuClpts7hpzHljCYa5MltFLrzohQ7DEnpj6kjG&amp;reftype=Substance&amp;refto=entrez&amp;reffrom=sidebar&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article|Navigation&amp;TO=Entrez|Crosslink|PubChem%20Substance&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pmc&amp;cmd=Display&amp;from_uid=209448&amp;dopt=pmc_pcsubstance">Substance</option></select><br><input type="image" src="corehtml/pmc/pmcgifs/go.gif" alt="Go" class="sidefm-pmart"></form></div><div class="sidebar-pubmed-author-box"><div class="sidefm-pmsubhead">PubMed articles by:</div><div class="sidefm-pmclink-item"><a href="redirect3.cgi?&amp;&amp;auth=0BaAWXmmTUJ02dNW1Rq05oo_Vxwn4oKgnOTAOS5lI&amp;reftype=authsrch&amp;refto=entrez&amp;reffrom=sidebar&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CNavigation&amp;TO=Entrez%7CPubMed%7CAuthor%20Search&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=PubMed&amp;term=%20Rollins+BJ%5Bauth%5D" class="sidefm-pmclink"> Rollins, B.</a></div></div></div></td><td rowspan="103" width="20px" height="300" background="corehtml/pmc/pmcgifs/wm-jcinvest.gif"><div style="width:20px"></div></td><td valign="top" class="content-cell"><div class="front-matter-section"><table cellspacing="0" cellpadding="0" width="100%"><tr style="vertical-align: top"><td><div class="fm-citation"><div><span class="citation-abbreviation">J Clin Invest. </span><span class="citation-publication-date">2001 November 1; </span><span class="citation-volume">108</span><span class="citation-issue">(9)</span><span class="citation-flpages">: 1269–1271. </span></div><div><span class="fm-vol-iss-date"> </span><span class="fm-vol-iss-date">doi: 10.1172/JCI14273.</span></div></div></td><td class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span>PMC209448</div></td></tr></table><div class="fm-copyright"><a class="int-reflink" href="about/copyright.html">Copyright</a>  &#x000a9; 2001, American Society for Clinical Investigation</div><div class="fm-title">Chemokines and atherosclerosis: what Adam Smith has to say about vascular disease</div><div class="fm-author contrib-group">Barrett J. Rollins<div class="fm-affl">Department of Adult Oncology, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women&#x02019;s Hospital,Harvard Medical School, Boston, Massachusetts, USA</div></div><div class="fm-footnote"></div><div class="fm-footnote"><div class="p">Address correspondence to: Barrett J. Rollins, Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts, USA. Phone: (617) 632-3896; Fax: (617) 632-5998; E-mail: <span class="e_id531147">barrett&#x0005f;rollins/at/dfci.harvard.edu</span><script type="text/javascript" language="JavaScript"><!--
                                    try{initUnObscureEmail ("e_id531147", '<a class="ext-reflink" href="' + reverseAndReplaceString('ude.dravrah.icfd/ta/snillor;f5000x#&tterrab:otliam', '/at/', '@') + '">' + reverseAndReplaceString('ude.dravrah.icfd/ta/snillor;f5000x#&tterrab', '/at/','@') + '</a>')}catch(e){}
                                //--></script>.</div></div><div class="links-box"><div class="fm-footnote"><img src="corehtml/pmc/pmcgifs/rt-arrow.gif" alt="Small right arrow pointing to:" style="vertical-align: middle;"> See the article "<a href="articlerender.fcgi?artid=209441" class="int-reflink">The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium</a>"  on page 1307.</div><div style="border-top: 1px solid rgb(102, 102, 153); margin: 5px 10% 3px;"></div><div class="fm-footnote"><img src="corehtml/pmc/pmcgifs/rt-arrow.gif" alt="Small right arrow pointing to:" style="vertical-align: middle;"> This article has been <a class="int-reflink" href="tocrender.fcgi?artid=209448&amp;action=cited">cited by</a> other articles in PMC.</div></div></div></td></tr><tr valign="top"><td class="sidebar-cell" width="145"><div class="side-section-group"><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#top" class="sidefm-pmclink" style="text-transform: none;">Top</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id476154" class="sidefm-pmclink" style="text-transform: none;">Chemokines and atherosclerosis</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id548667" class="sidefm-pmclink" style="text-transform: none;">The unexpected role of CXCR2 in the monocyte</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id674668" class="sidefm-pmclink" style="text-transform: none;">Specialization and the profusion of chemokines</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id533369" class="sidefm-pmclink" style="text-transform: none;">References</a></div></span></div></td><td class="content-cell"><div class="head1 section-title" style="text-transform: none;" id="id668406"> </div><div class="section-content">&#x0201c;The division of labor, so far as it can be introduced, occasions, in every art, a proportionable increase of the productive powers of labor.&#x0201d;<p>Adam Smith, <em>An Inquiry into the Nature and Causes of the Wealth of Nations, 1776</em></p><p>At the dawn of the industrial age, the social philosopher and economist Adam Smith wanted to explain how some countries were able to create what he called the &#x0201c;opulence&#x0201d; that other countries lacked. Smith suggested that the foremost driver of wealth was the division of labor because it directly results in increased productivity. In his famous example, one worker might make 20 pins a day, but when 10 workers divide the various tasks required to make a pin, they might make 48,000 a day, or an average of 4800 pins per worker per day. This concept is so powerful that it would be surprising if natural selection did not reward biological systems that do the same thing.</p><p>To pursue this idea, one might, by straining credulity right to the breaking point, draw an analogy between inflammation and manufacturing. The &#x0201c;product&#x0201d; is effector cell infiltration into target tissues, which is a complex, multistep process involving alterations in cell adhesion, motility, and gene expression. The &#x0201c;workers&#x0201d; are chemokines, an equally complex family of 50 or so small secreted proteins that are chemoattractants for the leukocytes that make up the infiltrate (<a href="#B1" class="cite-reflink bibr">1</a>). Here, then, is a system that seems tailor-made for the benefits of division of labor, and recent work on the function of chemokines in disease suggests that this is exactly what has happened.</p></div></td></tr><tr valign="top"><td class="sidebar-cell" width="145"><div class="side-section-group"><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#top" class="sidefm-pmclink" style="text-transform: none;">Top</a></div></span><div class="sidefm-pmccurrent-item"><a class="sidefm-pmclink" href="javascript:return(false);" style="text-transform: none;"><span class="sidebar-menu-square-image-holder"><img border="0" src="corehtml/pmc/pmcgifs/square.gif" alt="&gt;"></span>Chemokines and atherosclerosis</a></div><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id548667" class="sidefm-pmclink" style="text-transform: none;">The unexpected role of CXCR2 in the monocyte</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id674668" class="sidefm-pmclink" style="text-transform: none;">Specialization and the profusion of chemokines</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id533369" class="sidefm-pmclink" style="text-transform: none;">References</a></div></span></div></td><td class="content-cell"><div class="head1 section-title" style="text-transform: none;" id="id476154">Chemokines and atherosclerosis</div><div class="section-content"><p>One of the clearest examples of the essential role of chemokines in pathobiology involves atherosclerosis. In broad strokes, the inflammatory model of atherogenesis (<a href="#B2" class="cite-reflink bibr">2</a>) suggests that insults to endothelial or smooth muscle cells, such as hypercholesterolemia or flow shear stress, stimulate the production of leukocyte chemoattractants that are both displayed on the luminal surface of endothelial cells and also secreted into the subendothelium. When these factors activate their receptors on rolling leukocytes, this induces firm integrin-dependent adhesion to the endothelium, followed by diapedesis into the subendothelium. Among the most important of the migrating cells in this model are monocytes, which differentiate in situ into macrophages and take up cholesterol to become the foam cells of the fatty streak. The target cell specificity of the aptly named monocyte chemoattractant protein-1 (MCP-1) makes this chemokine a superb candidate for the signal that brings circulating monocytes into the vessel wall; MCP-1 attracts monocytes but not neutrophils, and it stimulates the adhesion of monocytes to endothelial cells (<a href="#B3" class="cite-reflink bibr">3</a>). Mice rendered genetically deficient for MCP-1 or its receptor, CCR2, are protected from vascular lesions in several atherosclerosis models (<a href="#B4" class="cite-reflink bibr">4</a>&#x02013;<a href="#B7" class="cite-reflink bibr">7</a>).</p><p>With such a tidy pathogenetic model available, perhaps it was understandable that many in the field have been disinclined to recognize the significance of studies implicating CXCR2 in atherogenesis. CXCR2 is the receptor for IL-8 and other CXC chemokines that have the three&#x02013;amino acid glutamate-leucine-arginine (ELR) motif near their N-termini. These chemokines are potent chemoattractants for neutrophils and not monocytes, the converse of MCP-1. Nonetheless, the relevance of CXCR2 to atherogenesis was demonstrated in a complicated but illuminating study in which atherosclerosis-prone mice were lethally irradiated and reconstituted with bone marrow donated by wild-type or CXCR2 knockout mice (<a href="#B8" class="cite-reflink bibr">8</a>). In the chimeras made with <em>CXCR2<sup>&#x02013;/&#x02013;</sup></em> bone marrow, hematopoietic cells (including, of course, monocytes) were CXCR2-deficient, and these mice had significantly less vascular disease than chimeras made with <em>CXCR2<sup>&#x0002b;/&#x0002b;</sup></em> bone marrow. The paradox posed by this study is that although CXCR2 is important for neutrophil chemoattraction, neutrophils are absent from this atherosclerosis model. What is CXCR2 doing here?</p></div></td></tr><tr valign="top"><td class="sidebar-cell" width="145"><div class="side-section-group"><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#top" class="sidefm-pmclink" style="text-transform: none;">Top</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id476154" class="sidefm-pmclink" style="text-transform: none;">Chemokines and atherosclerosis</a></div></span><div class="sidefm-pmccurrent-item"><a class="sidefm-pmclink" href="javascript:return(false);" style="text-transform: none;"><span class="sidebar-menu-square-image-holder"><img border="0" src="corehtml/pmc/pmcgifs/square.gif" alt="&gt;"></span>The unexpected role of CXCR2 in the monocyte</a></div><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id674668" class="sidefm-pmclink" style="text-transform: none;">Specialization and the profusion of chemokines</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id533369" class="sidefm-pmclink" style="text-transform: none;">References</a></div></span></div></td><td class="content-cell"><div class="head1 section-title" style="text-transform: none;" id="id548667">The unexpected role of CXCR2 in the monocyte</div><div class="section-content"><p>In retrospect, one notes early reports indicating that CXCR2 is expressed by monocytes (<a href="#B9" class="cite-reflink bibr">9</a>, <a href="#B10" class="cite-reflink bibr">10</a>). Furthermore, despite IL-8&#x02019;s inactivity in monocyte chemotaxis assays, this factor induces a calcium flux and respiratory burst in monocytes (<a href="#B11" class="cite-reflink bibr">11</a>) and enhances adhesion of monocytes in static assays (<a href="#B12" class="cite-reflink bibr">12</a>). Another ELR-containing CXC chemokine, GRO-&#x003b1;, similarly enhances adhesion to stimulated endothelial cells (<a href="#B13" class="cite-reflink bibr">13</a>). More recently, Gerszten et al. elegantly demonstrated IL-8&#x02019;s ability to induce firm arrest of monocytes on endothelial cells under conditions of physiological flow (<a href="#B14" class="cite-reflink bibr">14</a>). These results strongly suggest that CXCR2 and one or more of its ligands play a role in atherosclerosis. Even so, according to the model, MCP-1 and CCR2 should have compensated for the loss of CXCR2 in the chimeras. Insight into why this did not happen comes from work of Huo et al. (<a href="#B15" class="cite-reflink bibr">15</a>) in this issue of the <em>JCI</em>. These authors examined monocyte interactions with the endothelium of ex vivo perfused carotid arteries from a murine atherosclerosis model. First, they demonstrated that firm adhesion of monocytes to carotid endothelium was inhibited by pertussis toxin, suggesting the involvement of chemokine receptors which are G<sub>&#x003b1;i</sub>-linked. Then, the authors showed that at least two chemokines were displayed on the endothelial surface, namely MCP-1 and KC. The latter protein is the closest murine ortholog of the human chemokine GRO-&#x003b1;. Mice have no clear-cut IL-8 ortholog, although several known murine proteins are significantly homologous to it. Of these, KC appears to be the closest equivalent to IL-8, as judged by its pattern of expression and putative function. KC activates the murine receptor for ELR-containing CXC chemokines, which has, primarily for the sake of convenience, been denoted CXCR2.</p><p>The surprise came when Huo et al. (<a href="#B15" class="cite-reflink bibr">15</a>) attempted to block monocyte adhesion by interfering with specific chemokines. Despite the wealth of data indicating MCP-1&#x02019;s ability to stimulate monocyte arrest in vitro, Huo et al. found that neither anti&#x02013;MCP-1 nor an MCP-1 antagonist known as 9-76MCP-1 (<a href="#B16" class="cite-reflink bibr">16</a>) or 7ND (<a href="#B17" class="cite-reflink bibr">17</a>) prevented arrest in the perfused carotids. Rather, anti-KC and the KC antagonist 8-73GRO-&#x003b1; prevented monocyte arrest to the same extent as pertussis toxin. Hence, essentially all of the chemokine-mediated monocyte arrest in this model can be ascribed to KC, and none to MCP-1. Furthermore, since MCP-1&#x02013; and CCR2-deficient mice are protected from vascular disease, and since the 7ND inhibitor prevents atherosclerosis in vivo (<a href="#B18" class="cite-reflink bibr">18</a>), KC/CXCR2 must not be involved in monocyte transendothelial migration, only in adhesion. Conversely, since the CXCR2-deficient monocytes in the chimeras were protected, MCP-1/CCR2 must not be involved in adhesion, but only in migration. In other words, the chemokine system has evolved a strict division of labor and the model of chemokine involvement in atherosclerosis must be expanded to accommodate it (see Figure <a href="articlerender.fcgi?artid=209448&amp;rendertype=figure&amp;id=F1" class="fig-table-link " onclick="startTarget(this, 'figure', 1024, 800)">1</a>).</p><div style="margin: 1em; margin-right: 2em;        border: 1px solid #999999;border-left: 1px solid #AAAAAA;border-bottom: 1px solid #AAAAAA;"><div style="border: 3px solid #F0F0F0; border-left: 1px solid #F8F8F8; border-bottom: 1px solid #F8F8F8;"><a id="F1" name="F1"></a><table border="0" cellpadding="5" cellspacing="5" style="clear:both; width: 100%;"><tr valign="top" align="left"><td width="100" align="center"><a href="articlerender.fcgi?artid=209448&amp;rendertype=figure&amp;id=F1" class="icon-reflink" onclick="startTarget(this, 'figure', 1024, 800)"><img src="picrender.fcgi?artid=209448&amp;blobname=JCI0114273.f1.gif" border="1" class="icon-reflink" alt="Figure 1" title="Figure 1"></a></td><td><a class="side-caption" href="articlerender.fcgi?artid=209448&amp;rendertype=figure&amp;id=F1" onclick="startTarget(this, 'figure', 1024, 800)"><strong>Figure 1</strong></a><div class="figure-table-caption-in-article"><span>Chemokine receptors divide the labor of inflammatory infiltration. A monocyte engaged in selectin-mediated rolling on vascular endothelial cells is depicted as expressing CXCR2 (red) and CCR2 (green). First, interaction of CXCR2 with its ligand IL-8 (red</span><a class="side-caption" style="font-size: 100%;" href="articlerender.fcgi?artid=209448&amp;rendertype=figure&amp;id=F1" onclick="startTarget(this, 'figure', 1024, 800)"> (more ...)</a></div></td></tr></table></div></div><div style="clear:both;"></div></div></td></tr><tr valign="top"><td class="sidebar-cell" width="145"><div class="side-section-group"><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#top" class="sidefm-pmclink" style="text-transform: none;">Top</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id476154" class="sidefm-pmclink" style="text-transform: none;">Chemokines and atherosclerosis</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id548667" class="sidefm-pmclink" style="text-transform: none;">The unexpected role of CXCR2 in the monocyte</a></div></span><div class="sidefm-pmccurrent-item"><a class="sidefm-pmclink" href="javascript:return(false);" style="text-transform: none;"><span class="sidebar-menu-square-image-holder"><img border="0" src="corehtml/pmc/pmcgifs/square.gif" alt="&gt;"></span>Specialization and the profusion of chemokines</a></div><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id533369" class="sidefm-pmclink" style="text-transform: none;">References</a></div></span></div></td><td class="content-cell"><div class="head1 section-title" style="text-transform: none;" id="id674668">Specialization and the profusion of chemokines</div><div class="section-content"><p>Besides demonstrating that CXCR2 can be a therapeutic target in atherosclerosis, these results also have important biological implications. One of the enduring puzzles in the chemokine field is the large number of ligands and receptors that seem to have overlapping functions. On the ligand side, there are a dozen chemokines that attract neutrophils, another dozen that attract monocytes, and another dozen that attract T cells. On the receptor side, a single cell can express several chemokine receptors. Why should that be the case if a chemokine receptor is simply needed to get a cell from here to there? It appears now that these homologous proteins have different functions. We have known for some time that ELR-containing CXC chemokines that bind to CXCR2 with similar affinities actually elicit different responses from neutrophils (<a href="#B11" class="cite-reflink bibr">11</a>, <a href="#B19" class="cite-reflink bibr">19</a>). For example, some are more efficient chemoattractants while others are more efficient inducers of the respiratory burst.</p><p>The data from Huo et al. (<a href="#B15" class="cite-reflink bibr">15</a>) suggest that an analogous division of labor may exist among receptors. Perhaps monocytes require both CXCR2 and CCR2 because the former is more efficiently connected to the adhesion apparatus while the latter communicates more effectively with transmigration machinery. Rather than try to make one receptor do both things, nature has taken a page from <em>The Wealth of Nations</em> in order to increase the efficiency of inflammatory cell infiltration. In the case of atherosclerosis, of course, efficiency is not to be celebrated since it only enhances disease progression. However, the primary function of these cells is to protect us from foreign invaders, and in this context efficient responses should confer a great selective advantage. It will be interesting to see if, in other cases, the specialization of chemokines and chemokine receptors does indeed enhance the opulence of host protection.</p></div></td></tr><tr valign="top"><td class="sidebar-cell" width="145"> </td><td class="content-cell"><div class="head1 section-title" style="text-transform: none;" id="footnotes">Footnotes</div><div class="section-content"><div class="fm-footnote"><div class="p">See the related article beginning on page 1307.</div></div></div></td></tr><tr valign="top"><td class="sidebar-cell" width="145"><div class="side-section-group"><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#top" class="sidefm-pmclink" style="text-transform: none;">Top</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id476154" class="sidefm-pmclink" style="text-transform: none;">Chemokines and atherosclerosis</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id548667" class="sidefm-pmclink" style="text-transform: none;">The unexpected role of CXCR2 in the monocyte</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id674668" class="sidefm-pmclink" style="text-transform: none;">Specialization and the profusion of chemokines</a></div></span><div class="sidefm-pmccurrent-item"><a class="sidefm-pmclink" href="javascript:return(false);" style="text-transform: none;"><span class="sidebar-menu-square-image-holder"><img border="0" src="corehtml/pmc/pmcgifs/square.gif" alt="&gt;"></span>References</a></div></div></td><td class="content-cell"><div class="head1 section-title" style="text-transform: none;" id="id533369">References</div><div class="section-content"><div class="back-matter-section"><div class="ref-cit-blk" id="B1"><div class="ref-label">1.</div><div class="ref-cit">Rossi, D; Zlotnik, A. The biology of chemokines and their receptors. <span><span class="ref-journal">Annu Rev Immunol. </span>2000;<span class="ref-vol">18</span>:217–242.</span>  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0Zk5qM2LXSj0KkbAihIIwwZX15IGLziXyuRB3eQPg&amp;reftype=pubmed&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10837058">PubMed</a>]</span></div></div><div class="ref-cit-blk" id="B2"><div class="ref-label">2.</div><div class="ref-cit">Libby, P. Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. <span><span class="ref-journal">Am J Cardiol. </span>2000;<span class="ref-vol">86</span>:3–8.</span></div></div><div class="ref-cit-blk" id="B3"><div class="ref-label">3.</div><div class="ref-cit">Rollins, B. 2000. MCP-1, -2, -3, -4, -5. In <em>Cytokine reference.</em> J. Oppenheim et al., editors. Academic Press. London, United Kingdom. 1145&#x02013;1160.</div></div><div class="ref-cit-blk" id="B4"><div class="ref-label">4.</div><div class="ref-cit">Gu, L, et al.  Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. <span><span class="ref-journal">Mol Cell. </span>1998;<span class="ref-vol">2</span>:275–281.</span>  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0PG7qqfzxLisMfwVSpnOcQlLVPBzQW0mkgfUw7k__&amp;reftype=pubmed&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9734366">PubMed</a>]</span></div></div><div class="ref-cit-blk" id="B5"><div class="ref-label">5.</div><div class="ref-cit">Boring, L; Gosling, J; Cleary, M; Charo, IF. Decreased lesion formation in CCR2<sup>&#x02013;/&#x02013;</sup> mice reveals a role for chemokines in the initiation of atherosclerosis. <span><span class="ref-journal">Nature. </span>1998;<span class="ref-vol">394</span>:894–897.</span>  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0DgRmog3X9zfkjV-aqDamGjWzfAzAJu1MiKvSXAJO&amp;reftype=pubmed&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9732872">PubMed</a>]</span></div></div><div class="ref-cit-blk" id="B6"><div class="ref-label">6.</div><div class="ref-cit">Gosling, J, et al.  MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. <span><span class="ref-journal">J Clin Invest. </span>1999;<span class="ref-vol">103</span>:773–778.</span>  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0H78FblE6YdY6oxWgh16rzxzHZ42JqQt2svFTbk6I&amp;reftype=pubmed&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10079097">PubMed</a>]</span></div></div><div class="ref-cit-blk" id="B7"><div class="ref-label">7.</div><div class="ref-cit">Dawson, TC; Kuziel, WA; Osahar, TA; Maeda, N. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. <span><span class="ref-journal">Atherosclerosis. </span>1999;<span class="ref-vol">143</span>:205–211.</span>  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0Rak1sjWjOMoSTVLUpW555MVDhBg7VRMxpWkhSA6j&amp;reftype=pubmed&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10208497">PubMed</a>]</span></div></div><div class="ref-cit-blk" id="B8"><div class="ref-label">8.</div><div class="ref-cit">Boisvert, WA; Santiago, R; Curtiss, LK; Terkeltaub, RA. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. <span><span class="ref-journal">J Clin Invest. </span>1998;<span class="ref-vol">101</span>:353–363.</span>  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=02s7nm72zoBpQ3GTrxvZwJGVd39L6xNklcsN0pk-V&amp;reftype=pubmed&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9435307">PubMed</a>]</span></div></div><div class="ref-cit-blk" id="B9"><div class="ref-label">9.</div><div class="ref-cit">Moser, B, et al.  Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells. <span><span class="ref-journal">Biochem J. </span>1993;<span class="ref-vol">294</span>:285–292.</span>  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0pmM7nCSCPJmrjb2XKBMHJImGTMcnQ0ZwW7_alArQ&amp;reftype=pubmed&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/8363581">PubMed</a>]</span></div></div><div class="ref-cit-blk" id="B10"><div class="ref-label">10.</div><div class="ref-cit">Chuntharapai, A; Lee, J; Hebert, CA; Kim, KJ. Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. <span><span class="ref-journal">J Immunol. </span>1994;<span class="ref-vol">153</span>:5682–5688.</span>  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0Nmkav6NLoIQpdX9MzNi7E4xRWysAzkMzLdpOQkRf&amp;reftype=pubmed&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/7527448">PubMed</a>]</span></div></div><div class="ref-cit-blk" id="B11"><div class="ref-label">11.</div><div class="ref-cit">Walz, A; Meloni, F; Clark-Lewis, I; von Tscharner, V; Baggiolini, M. &#x0005b;Ca2&#x0002b;&#x0005d;i changes and respiratory burst in human neutrophils and monocytes induced by NAP-1/interleukin-8, NAP-2, and gro/MGSA. <span><span class="ref-journal">J Leukoc Biol. </span>1991;<span class="ref-vol">50</span>:279–286.</span>  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0fo-XXHYiAgldH-5yA9ZMV-6_Uo-OW-mUl17u0Qy2&amp;reftype=pubmed&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/1856598">PubMed</a>]</span></div></div><div class="ref-cit-blk" id="B12"><div class="ref-label">12.</div><div class="ref-cit">Lundahl, J; Skold, CM; Hallden, G; Hallgren, M; Eklund, A. Monocyte and neutrophil adhesion to matrix proteins is selectively enhanced in the presence of inflammatory mediators. <span><span class="ref-journal">Scand J Immunol. </span>1996;<span class="ref-vol">44</span>:143–149.</span>  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=04CiGBSO-F8qdgf5oH_TdxiOFYWqWt2J9wjt07AH6&amp;reftype=pubmed&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/8711427">PubMed</a>]</span></div></div><div class="ref-cit-blk" id="B13"><div class="ref-label">13.</div><div class="ref-cit">Schwartz, D, et al.  Role of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium. <span><span class="ref-journal">J Clin Invest. </span>1994;<span class="ref-vol">94</span>:1968–1973.</span>  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0D5gHvRf7cmUyqkoJfuc058mg8j_zrndVBm21YkGT&amp;reftype=pubmed&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/7962543">PubMed</a>]</span></div></div><div class="ref-cit-blk" id="B14"><div class="ref-label">14.</div><div class="ref-cit">Gerszten, RE, et al.  MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. <span><span class="ref-journal">Nature. </span>1999;<span class="ref-vol">398</span>:718–723.</span>  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0HcixeMw1I9CygMFYT3sk16P75smAq_C32rhlqAsz&amp;reftype=pubmed&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10227295">PubMed</a>]</span></div></div><div class="ref-cit-blk" id="B15"><div class="ref-label">15.</div><div class="ref-cit">Huo, Y, et al.  The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. <span><span class="ref-journal">J Clin Invest. </span>2001;<span class="ref-vol">108</span>:1307–1314.</span>  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=06URdFmVek4uTyLptOPhpSr1m9Wm3p50dfnDJSkE4&amp;reftype=pubmed&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/11696575">PubMed</a>]</span></div></div><div class="ref-cit-blk" id="B16"><div class="ref-label">16.</div><div class="ref-cit">Gong, JH; Clark-Lewis, I. Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH<sub>2</sub>-terminal residues. <span><span class="ref-journal">J Exp Med. </span>1995;<span class="ref-vol">181</span>:631–640.</span>  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0p50pQnqmtuxNEx6ltrZWnRmNR16KZAmtWpKBlQMc&amp;reftype=pubmed&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/7836918">PubMed</a>]</span></div></div><div class="ref-cit-blk" id="B17"><div class="ref-label">17.</div><div class="ref-cit">Zhang, YJ; Rutledge, BJ; Rollins, BJ. Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis: identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis. <span><span class="ref-journal">J Biol Chem. </span>1994;<span class="ref-vol">269</span>:15918–15924.</span>  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0VmRL_NSybg8CGB_2WBOkeNVwOB7Vnrq4rovSGkBw&amp;reftype=pubmed&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/8195247">PubMed</a>]</span></div></div><div class="ref-cit-blk" id="B18"><div class="ref-label">18.</div><div class="ref-cit">Ni, W, et al.  New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout Mice. <span><span class="ref-journal">Circulation. </span>2001;<span class="ref-vol">103</span>:2096–2101.</span>  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0fqyZRTqjIU3UxBxxJ__X9P79Su7TX44sNl3yVAvf&amp;reftype=pubmed&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/11319201">PubMed</a>]</span></div></div><div class="ref-cit-blk" id="B19"><div class="ref-label">19.</div><div class="ref-cit">Moser, B; Clark-Lewis, I; Zwahlen, R; Baggiolini, M. Neutrophil-activating properties of the melanoma growth-stimulating activity, MGSA. <span><span class="ref-journal">J Exp Med. </span>1990;<span class="ref-vol">171</span>:1797–1802.</span>  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0RU1sGVOgCvlNdToNkysBI2XpKBOiVgZvljJ_i5Gg&amp;reftype=pubmed&amp;artid=209448&amp;article-id=209448&amp;iid=6633&amp;issue-id=6633&amp;jid=120&amp;journal-id=120&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/2185333">PubMed</a>]</span></div></div></div></div></td></tr><tr><td></td><td class="content-cell"><div class="footer-section"><hr><div class="sans90" style="margin: 0em 1em 1em; text-align: center;">Articles from <span class="acknowledgment-journal-title">The Journal of Clinical Investigation</span> are provided here courtesy of <br><b>American Society for Clinical Investigation</b></div>
      <div class="footer-link" id="fp-footer">
        <div>
          <a class="link" href="mailto:pubmedcentral@nih.gov">Write to PMC</a>
           | 
          <a class="link" href="./">PMC Home</a>
           | 
          <a class="link" href="http://www.ncbi.nlm.nih.gov/pubmed">PubMed</a>
        </div>
        <div>
          <a class="link" href="http://www.ncbi.nlm.nih.gov">NCBI</a>
           | 
          <a class="link" href="http://www.nlm.nih.gov">U.S. National Library of Medicine</a>
        </div>
        <div>
          <a class="link" href="http://www.nih.gov">NIH</a>
           | 
          <a class="link" href="http://www.hhs.gov/">Department of Health and Human Services</a>
        </div>
        <div>
          <a class="link" href="about/privacypolicy.html">Privacy Policy</a>
           | 
          <a class="link" href="http://www.ncbi.nlm.nih.gov/About/disclaimer.html">Disclaimer</a>
           | 
          <a class="link" href="http://www.nih.gov/icd/od/foia/index.htm">Freedom of Information Act</a>
        </div>
      </div>
    </div></td></tr></table></body></html><!--host:ipmc3-->

